Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.
Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...
MedPage Today on MSN3d
Approval of Bevacizumab Biosimilar Could Eliminate Access to Low-Cost AMD TherapyCHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...
Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss ...
In data presented at the 128th annual meeting of the American Academy of Ophthalmology in Chicago, the two-year study finds ...
Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...
Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining the price ...
A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...
According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...
The quest to find a cure for the UK’s biggest cause of sight loss will be brought sharply into focus at a support group for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback